Molecular insights into regulation of JAK2 in myeloproliferative neoplasms.

Abstract:

:The critical role of Janus kinase-2 (JAK2) in regulation of myelopoiesis was established 2 decades ago, but identification of mutations in the pseudokinase domain of JAK2 in myeloproliferative neoplasms (MPNs) and in other hematologic malignancies highlighted the role of JAK2 in human disease. These findings have revolutionized the diagnostics of MPNs and led to development of novel JAK2 therapeutics. However, the molecular mechanisms by which mutations in the pseudokinase domain lead to hyperactivation of JAK2 and clinical disease have been unclear. Here, we describe recent advances in the molecular characterization of the JAK2 pseudokinase domain and how pathogenic mutations lead to constitutive activation of JAK2.

journal_name

Blood

journal_title

Blood

authors

Silvennoinen O,Hubbard SR

doi

10.1182/blood-2015-01-621110

subject

Has Abstract

pub_date

2015-05-28 00:00:00

pages

3388-92

issue

22

eissn

0006-4971

issn

1528-0020

pii

blood-2015-01-621110

journal_volume

125

pub_type

杂志文章,评审

相关文献

BLOOD文献大全
  • When a little aspirin may be enough.

    abstract::In this issue of Blood, Larocca et al in a large prospective study show that thromboprophylaxis with low-dose aspirin is very effective in previously untreated myeloma patients with a low thromboembolic risk receiving lenalidomide with low-dose dexamethasone. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2011-08-375089

    authors: Kastritis E,Dimopoulos MA

    更新日期:2012-01-26 00:00:00

  • Hematopoietic precursors resistant to treatment with 4-hydroperoxycyclophosphamide: requirement for an interaction with marrow stroma in addition to hematopoietic growth factors for maximal generation of colony-forming activity.

    abstract::We tested the ability of CD34+lin- precursor cells isolated from marrow after treatment with 4-hydroperoxycyclophosphamide (4HC) to generate colony-forming cells (CFC). In liquid cultures, recombinant human stem cell factor (SCF), in combination with interleukin-1 (IL-1), IL-3, IL-6, granulocyte-macrophage colony-stim...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rowley SD,Brashem-Stein C,Andrews R,Bernstein ID

    更新日期:1993-07-01 00:00:00

  • Randomized study on hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha 2b for chronic myeloid leukemia. The Benelux CML Study Group.

    abstract::Interferon-alpha (IFN-alpha) is considered the standard therapy for chronic myeloid leukemia (CML) patients not suitable for allogeneic stem cell transplantation. From 1987 through 1992, 195 patients in the Benelux with recent untreated CML were randomized between low-dose IFN-alpha2b (3 MIU, 5 days/wk) or hydroxyurea...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors:

    更新日期:1998-04-15 00:00:00

  • A critical role for TNFalpha in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles.

    abstract::Angiotensin II (Ang-II) exerts inflammatory activity and is involved in different cardiovascular disorders. This study has evaluated the involvement of tumor necrosis factor alpha (TNFalpha) in the leukocyte accumulation elicited by Ang-II. Ang-II (1 nM intraperitoneally in rats) induced TNFalpha release at 1 hour fol...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-01-070607

    authors: Mateo T,Naim Abu Nabah Y,Losada M,Estellés R,Company C,Bedrina B,Cerdá-Nicolás JM,Poole S,Jose PJ,Cortijo J,Morcillo EJ,Sanz MJ

    更新日期:2007-09-15 00:00:00

  • Autocrine interleukin-1 beta regulates both proliferation and apoptosis in EL4-6.1 thymoma cells.

    abstract::We demonstrate here that EL4-6.1 cells, a mouse thymoma that expresses high levels of membrane interleukin (IL)-1 receptors, produce IL-1 beta as an autocrine regulatory factor. Endogenous IL-1 beta sustains both proliferation and apoptosis: during the exponential phase, it mainly promotes proliferation, while during ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fratelli M,Gagliardini V,Galli G,Gnocchi P,Ghiara P,Ghezzi P

    更新日期:1995-06-15 00:00:00

  • Breaking barriers.

    abstract::It is difficult to imagine a greater challenge to the transplantation of haploidentical cells than thalassemia. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2009-11-254987

    authors: Woolfrey A

    更新日期:2010-02-11 00:00:00

  • Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.

    abstract::Protein tyrosine phosphorylation plays a crucial role in signaling from the receptor for erythropoietin (Epo), although the Epo receptor (EpoR) lacks the tyrosine kinase domain. We have previously shown that the Jak2 tyrosine kinase couples with the EpoR to transduce a growth signal. In the present study, we demonstra...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chin H,Arai A,Wakao H,Kamiyama R,Miyasaka N,Miura O

    更新日期:1998-05-15 00:00:00

  • International scoring system for evaluating prognosis in myelodysplastic syndromes.

    abstract::Despite multiple disparate prognostic risk analysis systems for evaluating clinical outcome for patients with myelodysplastic syndrome (MDS), imprecision persists with such analyses. To attempt to improve on these systems, an International MDS Risk Analysis Workshop combined cytogenetic, morphological, and clinical da...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Greenberg P,Cox C,LeBeau MM,Fenaux P,Morel P,Sanz G,Sanz M,Vallespi T,Hamblin T,Oscier D,Ohyashiki K,Toyama K,Aul C,Mufti G,Bennett J

    更新日期:1997-03-15 00:00:00

  • The primate erythrocyte complement receptor (CR1) as a privileged site: binding of immunoglobulin G to erythrocyte CR1 does not target erythrocytes for phagocytosis.

    abstract::The primate erythrocyte (E) complement receptor, CR1, is a transmembrane glycoprotein located in clusters on the surface of E. In vivo studies have demonstrated that during processing and clearance of complement-opsonized immune complexes, large amounts of immunoglobulin G (IgG) can be bound to primate E via CR1 with ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Reinagel ML,Gezen M,Ferguson PJ,Kuhn S,Martin EN,Taylor RP

    更新日期:1997-02-01 00:00:00

  • Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: induction of bax.

    abstract::CD40 is present on both normal and neoplastic B-lineage cells. CD40 stimulation of normal B cells has been shown to promote normal growth and differentiation, whereas aggressive histology B lymphomas are growth inhibited. The inhibition of neoplastic B-cell growth is believed to occur via activation-induced cell death...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v100.1.217

    authors: Szocinski JL,Khaled AR,Hixon J,Halverson D,Funakoshi S,Fanslow WC,Boyd A,Taub DD,Durum SK,Siegall CB,Longo DL,Murphy WJ

    更新日期:2002-07-01 00:00:00

  • Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia.

    abstract::To assess the influence of graft-versus-host disease (GVHD) on recurrent leukemia and survival after allogeneic marrow transplantation, we studied 1,202 patients with acute nonlymphocytic leukemia (ANL), acute lymphocytic leukemia (ALL), and chronic myelogenous leukemia (CML) given unmodified marrow grafts from HLA-id...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sullivan KM,Weiden PL,Storb R,Witherspoon RP,Fefer A,Fisher L,Buckner CD,Anasetti C,Appelbaum FR,Badger C

    更新日期:1989-05-01 00:00:00

  • Enhanced engraftment of hematopoietic progenitor cells in mice treated with granulocyte colony-stimulating factor before low-dose irradiation: implications for gene therapy.

    abstract::Gene therapy for inherited disorders of blood cells will require both efficient methods for stable gene transfer and nonablative bone marrow conditioning regimens to allow engraftment of modified hematopoietic progenitor cells (HPCs). We have used a sensitive murine system for detecting HPC engraftment using congenic ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mardiney M 3rd,Malech HL

    更新日期:1996-05-15 00:00:00

  • Detection of factor VIII inhibitors with the partial thromboplastin time.

    abstract::Variations of the partial thromboplastin time (PTT) were tested to determine the best screening method for detection of inhibitors of factor VIII. Variables tested included the duration of preincubation of a mixture of patient plasma and factor VIII source (normal plasma), the ratio of the patient plasma to the normal...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lossing TS,Kasper CK,Feinstein DI

    更新日期:1977-05-01 00:00:00

  • Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction.

    abstract::The therapeutic potential of hematopoietic stem cell (HSC) gene therapy can be fully exploited only by reaching efficient gene transfer into HSCs without compromising their biologic properties. Although HSCs can be transduced by HIV-derived lentiviral vectors (LVs) in short ex vivo culture, they display low permissivi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4047

    authors: Santoni de Sio FR,Cascio P,Zingale A,Gasparini M,Naldini L

    更新日期:2006-06-01 00:00:00

  • Normal T-cell telomerase activity and upregulation in human immunodeficiency virus-1 infection.

    abstract::In human immunodeficiency virus (HIV)-1 infection, decrease of telomere length is mainly found in CD8(+) T cells and not in CD4(+) T cells. Telomerase, a ribonucleoprotein enzyme that can synthesize telomeric sequence onto chromosomal ends, can compensate for telomere loss. Here, we investigated if telomerase activity...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wolthers KC,Otto SA,Wisman GB,Fleury S,Reiss P,ten Kate RW,van der Zee AG,Miedema F

    更新日期:1999-02-01 00:00:00

  • Fetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia.

    abstract::To evaluate the association between fetal hemoglobin (HbF) levels and morbidity in β-thalassemia intermedia (TI), we analyzed data from 63 untransfused patients who had also never received HbF induction therapy. Patient records were reviewed for any history of 10 predefined morbidities. Laboratory measurements for mar...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2011-09-382408

    authors: Musallam KM,Sankaran VG,Cappellini MD,Duca L,Nathan DG,Taher AT

    更新日期:2012-01-12 00:00:00

  • Schistosoma mansoni excretory circulating cathodic antigen shares Lewis-x epitopes with a human granulocyte surface antigen and evokes host antibodies mediating complement-dependent lysis of granulocytes.

    abstract::Parasitic worms of the genus Schistosoma excrete relatively large amounts of immunogenic glycoproteins (circulating cathodic antigen [CCA]) that contain polysaccharide side chains with the trisaccharide Lewis-x (L(ex)) as a repeating unit. These carbohydrates evoke high titers of specific IgM antibodies that cross-rea...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: van Dam GJ,Claas FH,Yazdanbakhsh M,Kruize YC,van Keulen AC,Ferreira ST,Rotmans JP,Deelder AM

    更新日期:1996-12-01 00:00:00

  • International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

    abstract::Human herpesvirus-8 (HHV-8)-negative, idiopathic multicentric Castleman disease (iMCD) is a rare and life-threatening disorder involving systemic inflammatory symptoms, polyclonal lymphoproliferation, cytopenias, and multiple organ system dysfunction caused by a cytokine storm often including interleukin-6. iMCD accou...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-10-746933

    authors: Fajgenbaum DC,Uldrick TS,Bagg A,Frank D,Wu D,Srkalovic G,Simpson D,Liu AY,Menke D,Chandrakasan S,Lechowicz MJ,Wong RS,Pierson S,Paessler M,Rossi JF,Ide M,Ruth J,Croglio M,Suarez A,Krymskaya V,Chadburn A,Colleoni

    更新日期:2017-03-23 00:00:00

  • Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B.

    abstract::The efficacy of the addition of intensive therapy with daunorubicin (45 mg/m2 IV on days 1, 2, 3) to an otherwise identical induction program consisting of vincristine, prednisone, and L-asparaginase was assessed in 177 previously untreated adults (greater than or equal to 20 years of age) with acute lymphocytic leuke...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Gottlieb AJ,Weinberg V,Ellison RR,Henderson ES,Terebelo H,Rafla S,Cuttner J,Silver RT,Carey RW,Levy RN

    更新日期:1984-07-01 00:00:00

  • Suppression of lymphocyte responses by monocytes with untreated and treated multiple myeloma.

    abstract::Studies were performed on 15 untreated and 14 treated patients with multiple myeloma. The monocyte content was normal in blood but elevated in mononuclear leukocytes (MNL) from treated but not untreated patients (p less than 0.001). This correlated with the severity of lymphopenia in blood (p less than 0.01). Three pa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Twomey JJ,Laughter AH,Rice L,Ford RJ

    更新日期:1982-08-01 00:00:00

  • Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma.

    abstract::Chimeric antigen receptor (CAR) T cells targeting CD19 have emerged as a leading engineered T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma. The phase 1/2 clinical trials that led to US Food and Drug Administration approval excluded patients with central nervous system (CNS) involvement, due to stri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019001694

    authors: Frigault MJ,Dietrich J,Martinez-Lage M,Leick M,Choi BD,DeFilipp Z,Chen YB,Abramson J,Crombie J,Armand P,Nayak L,Panzini C,Riley LS,Gallagher K,Maus MV

    更新日期:2019-09-12 00:00:00

  • Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for "prime time"?

    abstract::The past 40 years have witnessed major advances in defining the cytogenetic aberrations, mutational landscape, epigenetic profiles, and expression changes underlying hematological malignancies. Although it has become apparent that acute myeloid leukemia (AML) is highly heterogeneous at the molecular level, the standar...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2014-05-577593

    authors: Grimwade D,Freeman SD

    更新日期:2014-11-27 00:00:00

  • Subcellular localization of transforming growth factor-alpha in human eosinophil granulocytes.

    abstract::Eosinophils are involved in the inflammatory response seen in allergy and helminthic infestations. Eosinophils synthesize transforming growth factor-alpha (TGF-alpha), which may play a role in the development of the characteristic fibrosis seen in longstanding high eosinophilia. Using immunoelectron microscopic techni...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Egesten A,Calafat J,Knol EF,Janssen H,Walz TM

    更新日期:1996-05-01 00:00:00

  • Development of pluripotent hematopoietic progenitor cells in the human fetus.

    abstract::Pluripotent hematopoietic progenitor cells (CFU-GEMM), myeloid progenitor cells (CFU-GM), and erythroid progenitors (BFU-E) were studied in midtrimester human fetuses using the mixed colony assay. All three progenitor cell populations were detected at high levels in the fetal liver from 12 to 23 wk of gestation. Stem ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hann IM,Bodger MP,Hoffbrand AV

    更新日期:1983-07-01 00:00:00

  • Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular

    abstract::The Leukemia and Lymphoma Molecular Profiling Project recently published results from DNA microarray analyses of 240 diffuse large B-cell lymphomas (DLBCLs). Four gene expression "signatures" were identified as correlated with patient outcome, including the major histocompatibility complex (MHC) class II genes (eg, HL...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2365

    authors: Rimsza LM,Roberts RA,Miller TP,Unger JM,LeBlanc M,Braziel RM,Weisenberger DD,Chan WC,Muller-Hermelink HK,Jaffe ES,Gascoyne RD,Campo E,Fuchs DA,Spier CM,Fisher RI,Delabie J,Rosenwald A,Staudt LM,Grogan TM

    更新日期:2004-06-01 00:00:00

  • Erythropoiesis-stimulating factor production by rabbit kidney cultures from "programmed" rabbits.

    abstract::Rabbit kidney tissue either from normal rabbits or from rabbits "programmed" by phlebotomy or varying periods of hypoxia was cultured and shown to release into the culture medium an erythropoietically active substance. The cultures established from rabbits programmed by 6-12 hr of hypoxia yielded the highest levels of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ogle JW,Lange RD,Dunn CD

    更新日期:1978-07-01 00:00:00

  • Identification of base substitutions in the promoter regions of the A gamma- and G gamma-globin genes in A gamma- (or G gamma-) beta+-HPFH heterozygotes using the DNA-amplification-synthetic oligonucleotide procedure.

    abstract::DNA amplification combined with hybridization with 32P-labeled synthetic oligonucleotide probes has been used to identify base substitutions in the 5' promoter region of the A gamma globin gene in members of eleven families from China, Sardinia, Canada, and the United States who had a heterozygosity for the A gamma-be...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yang KG,Stoming TA,Fei YJ,Liang S,Wong SC,Masala B,Huang RB,Wei ZP,Huisman TH

    更新日期:1988-05-01 00:00:00

  • Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia.

    abstract::Allelic loss at nonrandom chromosomal sites is thought to mark the position of tumor suppressor genes involved in the pathogenesis and progression of human malignancies. Solid tumors in particular have been found to harbor multiple genetic changes resulting in loss of function mutations. Tumor suppressor genes have al...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bullrich F,Veronese ML,Kitada S,Jurlander J,Caligiuri MA,Reed JC,Croce CM

    更新日期:1996-10-15 00:00:00

  • BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks.

    abstract::The oncogenic BCR/ABL tyrosine kinase induces constitutive DNA damage in Philadelphia chromosome (Ph)-positive leukemia cells. We find that BCR/ABL-induced reactive oxygen species (ROSs) cause chronic oxidative DNA damage resulting in double-strand breaks (DSBs) in S and G(2)/M cell cycle phases. These lesions are rep...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-05-1941

    authors: Nowicki MO,Falinski R,Koptyra M,Slupianek A,Stoklosa T,Gloc E,Nieborowska-Skorska M,Blasiak J,Skorski T

    更新日期:2004-12-01 00:00:00

  • Virus-specific T-cell therapies for patients with primary immune deficiency.

    abstract::Viral infections are common and are potentially life-threatening in patients with moderate to severe primary immunodeficiency disorders. Because T-cell immunity contributes to the control of many viral pathogens, adoptive immunotherapy with virus-specific T cells (VSTs) has been a logical and effective way of combatin...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood.2019000924

    authors: Keller MD,Bollard CM

    更新日期:2020-02-27 00:00:00